Valuation : Galenica AG

Market Cap 4.13B 5.1B 4.39B 3.77B 7.06B 482B 7.08B 48.81B 18.94B 247B 19.16B 18.74B 796B P/E 2026 *
25x
P/E 2027 * 20x
Enterprise Value 5B 6.17B 5.31B 4.57B 8.54B 583B 8.57B 59.07B 22.92B 299B 23.19B 22.68B 964B EV / Sales 2026 *
1.14x
EV / Sales 2027 * 1.09x
Free-Float
99.39%
Yield 2026 *
3.07%
Yield 2027 * 3.23%
1 day-2.27%
1 week+1.94%
Current month+3.43%
1 month+1.51%
3 months+2.53%
6 months-8.18%
Current year-12.03%
1 week 82.7
Extreme 82.7
85.95
1 month 80.45
Extreme 80.45
85.95
Current year 80.45
Extreme 80.45
103
1 year 80.45
Extreme 80.45
103
3 years 65.2
Extreme 65.2
103
5 years 60.65
Extreme 60.65
103
10 years 39
Extreme 39
103
Manager TitleAgeSince
Chief Executive Officer 59 2020-03-31
Director of Finance/CFO 44 2024-12-31
Chief Tech/Sci/R&D Officer 54 2021-12-31
Director TitleAgeSince
Director/Board Member 61 2017-12-31
Chairman 68 2023-05-02
Director/Board Member 49 2019-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-2.27%+1.94% - - 5.1B
-1.45%+1.63%+32.09%+123.02% 106B
-0.58%+5.38%+65.27%+184.41% 57.49B
+0.37%+0.75%-11.18%+248.39% 22.39B
+1.09%+1.28%-9.33%-5.62% 8.26B
-0.33%-1.05%-37.27%-28.46% 7.15B
-0.59%+6.52%+6.47%+28.26% 6.79B
+1.49%-1.51%-15.46%-25.82% 6.24B
-0.24%-1.72%-5.85%+20.23% 5.1B
+1.71%+6.91%+323.81%+481.22% 4.56B
Average -0.08%+2.54%+38.73%+113.96% 24.87B
Weighted average by Cap. -0.75%+3.54%+35.52%+139.67%

Financials

2026 *2027 *
Net sales 4.39B 5.42B 4.66B 4.01B 7.5B 512B 7.52B 51.83B 20.11B 262B 20.34B 19.9B 845B 4.53B 5.59B 4.81B 4.14B 7.74B 528B 7.76B 53.5B 20.76B 271B 21B 20.54B 873B
Net income 169M 209M 180M 154M 289M 19.72B 290M 2B 775M 10.12B 784M 767M 32.6B 207M 255M 220M 189M 353M 24.08B 354M 2.44B 947M 12.36B 958M 937M 39.81B
Net Debt 868M 1.07B 923M 793M 1.48B 101B 1.49B 10.26B 3.98B 51.96B 4.03B 3.94B 167B 807M 997M 858M 737M 1.38B 94.15B 1.38B 9.54B 3.7B 48.3B 3.74B 3.66B 156B
Logo Galenica AG
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Employees
6,623
Date Price Change Volume
26-09-04 CHF 82.90 -0.56% 12,852
26-09-03 CHF 83.37 +0.24% 1,143
26-09-02 CHF 83.17 -0.04% 3,158
26-09-01 CHF 83.20 +0.12% 4,420
26-08-31 CHF 83.10 -1.44% 5,726
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
82.90CHF
Average target price
87.60CHF
Spread / Average Target
+5.67%

Annual profits - Rate of surprise